Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer

NCT03964337 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor accrual.

Conditions

Prostate Cancer
Prostate Cancer Adenocarcinoma
Non-Metastatic

Interventions

DRUG: Cabozantinib
PROCEDURE: Radical Prostatectomy

Sponsor

Duke University

Collaborators

[object Object]